La base de données de suivi, d'évaluation et de rapport (MER) PEPFAR de l'amfAR est un outil gratuit conçu pour aider les défenseurs, les décideurs et les communautés à surveiller les performances du programme PEPFAR. La base de données se veut une source complète de données sur les objectifs et les performances publiquement disponibles publiées par le programme PEPFAR.
Accéder à l'outil complet: https://mer.amfar.org/
This tool provides country-level data showing 90-90-90 progress towards 2020 targets using Global AIDS Monitoring (UNAIDS/WHO/UNICEF) data and Spectrum estimates (UNAIDS/WHO).
This RRHO video describes the basic principles of standard operating procedures (SOP). This video can support organization staff to understand the importance of SOPs to improve workplace productivity and quality, save time and reduce errors, reduce training needs, enable the delegation of work duties, and empower employees.
Mobile phones and social media, such as WhatsApp and Facebook, are highly popular among Nurses and Midwives and are widely used for professional purposes. Although research found that there are considerable benefits for nurses and midwives linked to the use of these apps, they also give rise to significant challenges and risks. The ill-informed use of these apps has negatively affected client confidentiality, security, and safety and it has damaged individual careers and caused harm to the entire profession. In response to these issues, the General Nursing Council of Zambia has developed guidelines to help Nurses and Midwives to successfully navigate the new world of digital professionalism. However, the guidelines cover many, but not all, situations and in the light of the complexity and the changing nature of digital media, every Nurse and Midwife is cautioned to apply due diligence in the specific situations that they encounter.
The key aim of this guideline is to present recommendations based on a critical evaluation of the evidence on emerging digital health interventions that are contributing to health system improvements, based on an assessment of the benefits, harms, acceptability, feasibility, resource use and equity considerations. This guideline urges readers to recognize that digital health interventions are not a substitute for functioning health systems, and that there are significant limitations to what digital health is able to address.
Lopinavir/ritonavir (LPV/r) pellets are a new formulation of a pediatric HIV medicine. The LPV/r Pellet Toolkit provides information on how to implement rollout of LPV/r pellets into the national health care system in the Rollout Planning and Management section. The toolkit also provides clinical information on LPV/r pellets in the Health Care Worker section, including recommendations on dosing and administration of the medication, as well as resources for working with caregivers. The information in the LPV/r Pellet Toolkit can be accessed on mobile smart phones and tablets as well as laptops, and the pages and tools are available to download for offline use.
Cette vidéo décrit la création et l'utilisation efficaces de discours d'ascenseur afin de sensibiliser les organisations et de soutenir les objectifs de communication et de mobilisation des ressources. Cette vidéo peut être utilisée pour compléter des sessions de formation afin de s'assurer que tout le personnel de l'organisation est prêt à fournir des informations concises et convaincantes aux représentants des gouvernements, aux donateurs potentiels, aux clients ou aux membres.
This RRHO video describes creating and using elevator speeches effectively to create awareness of an organization and support both communication and resource mobilization objectives. This video can be used to supplement training sessions to ensure all organization staff are prepared to deliver concise and compelling information to government officials, potential donors, clients, or members.
PEPFAR Solutions are impactful, data-proven HIV implementing experiences that can serve as 'how to' guides for others.
Considerations for the Introduction of TLD in National Programs: PEPFAR Guidance on Developing Clinical and Programmatic RecommendationsICAP, 2018
This document supports country program managers to develop clinical guidance and implementation plans for the introduction of the fixed-dose combination tablet of tenofovir, lamivudine and dolutegravir (TLD). It combines summaries of current normative guidance, available evidence, and programmatic considerations to inform the practical decisions that countries will need to make to develop comprehensive guidance on the use of TLD.